Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06074744
Other study ID # SSNB2023
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2023
Est. completion date December 2026

Study information

Verified date March 2024
Source Luzerner Kantonsspital
Contact Judith Bering, Dr. med.
Phone +41 41 205 18 91
Email judith.bering@luks.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: - is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: - receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) - receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : - functional muscle power output of the leg? - muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?


Description:

Prospective, randomized, double-blinded, single-center, controlled clinical trial with intervention group (SSNB + IPACK, group 1) and control group (FNB + IPACK, group 2), randomization by sealed envelopes. The number of participants will be 72 per group, calculated based on a sample size calculator program. The 3 surgeons will be blinded as well as the patients regarding the nerve block they will receive. We will explain to the patients how both the blocks will be carried out, that 1 block will be located "higher on the leg" and 1 "lower on the leg". The nerve blocks will be carried out by a well-trained anaesthesiologist following standard procedures preoperative. The IPACK will be applied by the surgeons intraoperative, following a standard protocol. The used implant for all patients will be the cemented ATTUNE™ Primary Knee System® (DePuySynthes Johnson&Johnson). Every patient will wear a brace fixed in full extension after surgery for the first 24 hours. Postoperative all patients will receive a standard set of adequate analgesics. The postoperative rehabilitation program will follow our well-established physiotherapy scheme. Performed assessments: - Range of motion (ROM) - medical history - physical examinations - radiologic controls - adverse events - falls during hospital stay (standard protocol) - pain assessment (numeric rating scale) - Questionnaires (EQ-5D-5L und Oxford Knee Score) will be filled in by the patients - Functional assessment: Cycle sprint test one a specially instrumented indoor bike (Verve Info Tec PTY LTD) fit with an instrumented crank (InfoCrank Power Meter, Verve Cycling, West Perth, Australia) - Functional assessment: Manual muscle testing (MMT) - Functional assessment: Timed up and go test (TUG) Superiority analysis using a two sample t-test, significance level 0.05, power 80%. Data will be stored electronically in the data base (RedCap). In case of missing data there will always be attempts to obtain these data afterwards (contacting the patients by phone). Further on statistical analysis is performed. Dropouts, before the 6 weeks follow-up, will be replaced by recruitment of new subjects. For quality assurance the sponsor, the Ethics Committee or an independent trial monitor may visit the research sites.


Recruitment information / eligibility

Status Recruiting
Enrollment 144
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - age > 18yrs - primary TKA - BMI 35kg/m2 or less - able to give informed consent as documented by signature - clinical history without any contraindications for the planned intervention Exclusion criteria: - age < 18 years - revision-TKA - BMI >35kg/m2 - absent contact information - inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases - pregnancy - inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc. - withdrawal from the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
SSNB + IPACK
already included in arm/group description
FNB + IPACK
already included in arm/group description

Locations

Country Name City State
Switzerland Luzerner Kantonsspital Luzern

Sponsors (1)

Lead Sponsor Collaborator
Luzerner Kantonsspital

Country where clinical trial is conducted

Switzerland, 

References & Publications (44)

Abdallah FW, Whelan DB, Chan VW, Prasad GA, Endersby RV, Theodoropolous J, Oldfield S, Oh J, Brull R. Adductor Canal Block Provides Noninferior Analgesia and Superior Quadriceps Strength Compared with Femoral Nerve Block in Anterior Cruciate Ligament Reconstruction. Anesthesiology. 2016 May;124(5):1053-64. doi: 10.1097/ALN.0000000000001045. — View Citation

Atkinson HD, Hamid I, Gupte CM, Russell RC, Handy JM. Postoperative fall after the use of the 3-in-1 femoral nerve block for knee surgery: a report of four cases. J Orthop Surg (Hong Kong). 2008 Dec;16(3):381-4. doi: 10.1177/230949900801600324. — View Citation

Barry E, Galvin R, Keogh C, Horgan F, Fahey T. Is the Timed Up and Go test a useful predictor of risk of falls in community dwelling older adults: a systematic review and meta-analysis. BMC Geriatr. 2014 Feb 1;14:14. doi: 10.1186/1471-2318-14-14. — View Citation

Brull R, McCartney CJ, Chan VW, El-Beheiry H. Neurological complications after regional anesthesia: contemporary estimates of risk. Anesth Analg. 2007 Apr;104(4):965-74. doi: 10.1213/01.ane.0000258740.17193.ec. — View Citation

Bundesamt für Statistik, Schweiz

Burket LW, Greenberg MS, Glick M. Burkett's Textbook of Oral Medicine. 10th ed. Philadelphia, PA: Lippincott

Chan E, Howle R, Onwochei D, Desai N. Infiltration between the popliteal artery and the capsule of the knee (IPACK) block in knee surgery: a narrative review. Reg Anesth Pain Med. 2021 Sep;46(9):784-805. doi: 10.1136/rapm-2021-102681. Epub 2021 May 14. — View Citation

Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S208-28. doi: 10.1002/acr.20632. No abstract available. — View Citation

Common Terminology Criteria for Adverse Events (CTCAE) https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf

Declaration of Helsinki, Version October 2013

Edwards ND, Wright EM. Continuous low-dose 3-in-1 nerve blockade for postoperative pain relief after total knee replacement. Anesth Analg. 1992 Aug;75(2):265-7. doi: 10.1213/00000539-199208000-00020. — View Citation

EQ-5D-3L Manual Guide. Euroquol.org. 2021 [cited 28 March 2021]. vailable from: https://euroquol.org/wp-content/uploads/2019/10/EQ-5D-3L-User-Guide_version-6.0.pd

Everhart JS, Hughes L, Abouljoud MM, Swank K, Lewis C, Flanigan DC. Femoral nerve block at time of ACL reconstruction causes lasting quadriceps strength deficits and may increase short-term risk of re-injury. Knee Surg Sports Traumatol Arthrosc. 2020 Jun;28(6):1894-1900. doi: 10.1007/s00167-019-05628-7. Epub 2019 Jul 17. — View Citation

Fan Chiang YH, Wang MT, Chan SM, Chen SY, Wang ML, Hou JD, Tsai HC, Lin JA. Motor-Sparing Effect of Adductor Canal Block for Knee Analgesia: An Updated Review and a Subgroup Analysis of Randomized Controlled Trials Based on a Corrected Classification System. Healthcare (Basel). 2023 Jan 10;11(2):210. doi: 10.3390/healthcare11020210. — View Citation

Federal Act on Data Protection (FADP) https://www.admin.ch/opc/en/classified-compilation/19920153/index.html

Feibel RJ, Dervin GF, Kim PR, Beaule PE. Major complications associated with femoral nerve catheters for knee arthroplasty: a word of caution. J Arthroplasty. 2009 Sep;24(6 Suppl):132-7. doi: 10.1016/j.arth.2009.04.008. Epub 2009 Jun 24. — View Citation

Grosu I, Lavand'homme P, Thienpont E. Pain after knee arthroplasty: an unresolved issue. Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1744-58. doi: 10.1007/s00167-013-2750-2. Epub 2013 Nov 8. — View Citation

Guo J, Hou M, Shi G, Bai N, Huo M. iPACK block (local anesthetic infiltration of the interspace between the popliteal artery and the posterior knee capsule) added to the adductor canal blocks versus the adductor canal blocks in the pain management after total knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2022 Aug 12;17(1):387. doi: 10.1186/s13018-022-03272-5. — View Citation

Hasabo EA, Assar A, Mahmoud MM, Abdalrahman HA, Ibrahim EA, Hasanin MA, Emam AK, AbdelQadir YH, AbdelAzim AA, Ali AS. Adductor canal block versus femoral nerve block for pain control after total knee arthroplasty: A systematic review and Meta-analysis. Medicine (Baltimore). 2022 Aug 26;101(34):e30110. doi: 10.1097/MD.0000000000030110. — View Citation

Human Research Act (HRA) https://www.admin.ch/opc/de/classified-compilation/20061313/index.html

Hurworth M, Evans JM, Gibbons R, Mackie KE, Edmondston SJ. Cycle Sprint Test for the Evaluation of Lower Limb Muscle Power After Total Knee Arthroplasty: A Proof-of-Concept Study. Arthroplast Today. 2021 Jun 15;9:118-121. doi: 10.1016/j.artd.2021.05.007. eCollection 2021 Jun. — View Citation

Implantatregister SIRIS Hüfte und Knie: Kurzfassung - SIRIS Report 2022

International Conference on Harmonization (ICH) E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002749.pdf

International Conference on Harmonization (ICH) E6(R2) Guideline for Good Clinical Practice

International Conference on Harmonization (ICH, 1997) E8 Guideline: General Considerations for Clinical Trials

Lam CLK, Tse ETY, Wong CKH, Lam JSM, Chen SS, Bedford LE, Cheung JPY, Or CK, Kind P. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice. Health Qual Life Outcomes. 2021 Dec 18;19(1):266. doi: 10.1186/s12955-021-01898-3. — View Citation

Li D, Alqwbani M, Wang Q, Liao R, Yang J, Kang P. Efficacy of Adductor Canal Block Combined With Additional Analgesic Methods for Postoperative Analgesia in Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. J Arthroplasty. 2020 Dec;35(12):3554-3562. doi: 10.1016/j.arth.2020.06.060. Epub 2020 Jun 24. — View Citation

Luo TD, Ashraf A, Dahm DL, Stuart MJ, McIntosh AL. Femoral nerve block is associated with persistent strength deficits at 6 months after anterior cruciate ligament reconstruction in pediatric and adolescent patients. Am J Sports Med. 2015 Feb;43(2):331-6. doi: 10.1177/0363546514559823. Epub 2014 Dec 2. — View Citation

Ma HH, Chou TA, Tsai SW, Chen CF, Wu PK, Chen WM. The efficacy of continuous versus single-injection femoral nerve block in Total knee Arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020 Feb 24;21(1):121. doi: 10.1186/s12891-020-3148-1. — View Citation

Mansour NY. Sub-sartorial saphenous nerve block with the aid of nerve stimulator. Reg Anesth. 1993 Jul-Aug;18(4):266-8. No abstract available. — View Citation

Maye A, Hurley E, Jamal M, Curley G. Adductor canal block versus femoral nerve block in total knee arthroplasty: a Meta-Analysis of randomized control trials. ESRA 2019 19-0449

Mou P, Wang D, Tang XM, Zeng WN, Zeng Y, Yang J, Zhou ZK. Adductor Canal Block Combined With IPACK Block for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. J Arthroplasty. 2022 Feb;37(2):259-266. doi: 10.1016/j.arth.2021.10.004. Epub 2021 Oct 13. — View Citation

Ordinance on Clinical Trials in Human Research (ClinO) https://www.admin.ch/opc/de/classified-compilation/20121176/index.html

Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. doi: 10.1111/j.1532-5415.1991.tb01616.x. — View Citation

Rosenblatt RM. Continuous femoral anesthesia for lower extremity surgery. Anesth Analg. 1980 Aug;59(8):631-2. No abstract available. — View Citation

Runner RP, Boden SA, Godfrey WS, Premkumar A, Samady H, Gottschalk MB, Xerogeanes JW. Quadriceps Strength Deficits After a Femoral Nerve Block Versus Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective, Single-Blinded, Randomized Trial. Orthop J Sports Med. 2018 Sep 26;6(9):2325967118797990. doi: 10.1177/2325967118797990. eCollection 2018 Sep. — View Citation

Sharma S, Iorio R, Specht LM, Davies-Lepie S, Healy WL. Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468(1):135-40. doi: 10.1007/s11999-009-1025-1. Epub 2009 Aug 13. — View Citation

Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903. — View Citation

Sinha S, Abras J, Sivasenthil D. Use of ultrasound guided popliteal fossa infiltration to control pain after total knee arthroplasty: a prospective randomized observer-blinded study. ASRA 37th Annual Regional Anesthesia Meeting and Workshops; March 15-18, San Diego, CA, 2012

Stocks GW, Odoemene M, Gex J, Vidal EA, Sawyer K, Jones SL, Thompson B, Laughlin MS. Quadriceps Strain and TKA: Contribution of the Tourniquet and Intramedullary Rod to Postoperative Thigh Pain: A Randomized Controlled Trial. J Bone Joint Surg Am. 2023 Mar 15;105(6):455-461. doi: 10.2106/JBJS.22.00703. Epub 2023 Jan 9. — View Citation

Tierney E, Lewis G, Hurtig JB, Johnson D. Femoral nerve block with bupivacaine 0.25 per cent for postoperative analgesia after open knee surgery. Can J Anaesth. 1987 Sep;34(5):455-8. doi: 10.1007/BF03014348. — View Citation

van der Wal M, Lang SA, Yip RW. Transsartorial approach for saphenous nerve block. Can J Anaesth. 1993 Jun;40(6):542-6. doi: 10.1007/BF03009739. — View Citation

Winnie AP, Ramamurthy S, Durrani Z. The inguinal paravascular technic of lumbar plexus anesthesia: the "3-in-1 block". Anesth Analg. 1973 Nov-Dec;52(6):989-96. No abstract available. — View Citation

Wright, W. Muscle training in the treatment of infantile paralysis. Boston Med. Surg. J. 1912, 167, 567-574

* Note: There are 44 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Functional muscle power output of the leg Cycle sprint test measuring maximum lower limb muscle power in Watts (W) from 3 times 10-second maximal efforts (higher values better) preoperative, 6 weeks, 12 weeks, 1 year after surgery
Secondary Muscle strength Manual muscle testing (MMT) as a standardized measuring tool to assess quadriceps muscle strength using a numeric score 0-5 (Daniels and Worthingham Scale): patient in sitting position in 20 degree knee flexion is asked to extend the knee actively against resistance proximal to the ankle (higher values better) preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
Secondary Mobility Timed up and go test (TUG): standardized measuring tool, the patient is timed while they rise from an arm chair (approximate seat height 46 cm), walk at a comfortable and safe pace to a line on the floor 3 metres away, turn and walk back to the chair and sit down again (in seconds) (lower values better) preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks1 year after surgery
Secondary Clinical results redness, swelling, hyperthermia, wound/scar, range of motion, stability, adverse events preoperative, day of discharge (7+/- 2 days postoperative), 6, 12 weeks, 1 year after surgery
Secondary Radiological results x-rays ap and lateral view(1), patella(2), whole leg axis(3) preoperative(1-3), day 1 after surgery(1), 6 weeks(1-2), 1 year after surgery(1-3)
Secondary Pain control numeric rating scale 0-10 (lower values better) before surgery, twice daily on the ward (except first 6 hours: hourly), day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
Secondary Opioid consumption documentation of administered drugs including name of drug, dosage, frequency of use before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
Secondary Length of hospital stay documentation of days in hospital before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
Secondary Patient satisfaction 1 Questionnaire (Oxford Knee Score) 12-60 points (lower values better) preoperative, 6 weeks, 12 weeks, 1 year after surgery
Secondary Patient satisfaction 2 Questionnaire (EQ-5D-5L) 5 questions with 5 answers each (lower values better) including EQ-VAS 0-100 (higher values better) preoperative, 6 weeks, 12 weeks, 1 year after surgery
See also
  Status Clinical Trial Phase
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Not yet recruiting NCT03726788 - Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis Phase 2
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Completed NCT02604446 - Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo Phase 3
Completed NCT02269254 - Persona Versus NexGen N/A
Completed NCT02256098 - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA N/A
Completed NCT00815243 - Telemedicine Consultation in Trauma and Orthopedic N/A
Recruiting NCT05564182 - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain N/A
Recruiting NCT06142669 - EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol
Enrolling by invitation NCT04147559 - Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem
Terminated NCT02591368 - MiniTightRope Suspensionplasty Compared With LRTI for the Treatment of Basilar Thumb Arthritis N/A
Completed NCT01227694 - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis Phase 1/Phase 2
Completed NCT00784277 - A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease Phase 3
Active, not recruiting NCT05618782 - Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee Phase 2
Recruiting NCT04029792 - Evaluation of a Combination of Plant Extracts (BSL_EP028) on Joint Mobility Phase 1/Phase 2
Active, not recruiting NCT06404346 - Comparative Effectiveness of HVT and Bowen Technique in Patients of SI Joint Dysfunction With Upslipped Innominates N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A
Completed NCT05650970 - Radial Nerve Mobilization in Hand Thumb Osteoarthritis Patients N/A
Completed NCT02315664 - MONITOR-OA: Using Wearable Activity Trackers to Improve Physical Activity in Knee Osteoarthritis N/A
Completed NCT05241691 - Retrospective Evaluation of GGPSP's Safety and Clinical Performance for the Treatment of Lower Limbs Deformities.